Tag: hormoneReceptorPositive

Hormone receptor positive (ER+/PR+): Breast cancer that is estrogen receptor positive (ER+) and progesterone receptor positive (PR+). Some researchers classify mixed hormone receptor disease such as ER+/PR- as hormone receptor positive.

Articles

News

05/12/21
Tamoxifen increases long-term survival in women with large tumor size
01/02/21
Low levels of omega-3 fats linked to increased bone metastasis
02/25/18
Cucumber has anti-cancer activities in ER+, HER2+ and TN cells
12/16/17
Melatonin enhances the treatment effects of Taxotere in ER+/PR+ BC
11/12/17
The pesticide endosulfan, once widely used, promotes breast cancer
04/01/17
Saffron carotenoid crocin inhibits breast cancer cell division
10/09/16
Melatonin reduces the viability of both ER+ and ER- BC stem cells
06/27/16
Gamma-tocotrienol form of vitamin E suppresses BC metastasis
05/22/16
Plant-based omega-3 fatty acid ALA reduces ER+/PR+ BC growth
05/16/16
Fruit consumption in adolescence linked to lower BC risk
04/08/16
Genistein could reduce treatment effects of Adriamycin in ER+/PR+ BC
02/21/16
HDL from BC patients with type 2 diabetes can promote metastasis
10/18/15
Late recurrence of ER+ breast cancer is more likely for some women
10/06/15
Pink Lady apple peel inhibits ER+/PR+ breast cancer growth
03/29/15
Kaempferol reduces ER+/PR+ breast cancer proliferation
02/22/15
Blueberry and ginger compounds enhance Taxol treatment effects
10/05/14
Walnut compounds impair BC energy supply and induce cell death
06/29/14
Arugula compound erucin inhibits proliferation of ER+ BC cells
04/26/14
Kaempferol reduces ER+/PR+ growth and protects against triclosan
12/15/13
Even low phthalate exposure can increase BC cell proliferation
11/25/13
Whole blueberry powder reduces breast cancer formation and growth
11/16/13
Fish oil reduces lung metastases in mouse model of breast cancer
10/28/13
Salad and wine dietary pattern increases breast cancer risk
08/18/13
Cadmium reduces effectiveness of 5-FU chemotherapy in ER+/PR+ cells
07/27/13
Aluminum increases migration and invasion of ER+ breast cancer cells
06/16/13
Resveratrol enhances the effectiveness of Adriamycin in ER+/PR+ cells
05/07/13
Luteolin improves treatment in tamoxifen-resistant BC
03/29/13
Blueberry compound inhibits BC stem cell generation and activities
02/22/13
Coffee may reduce risk of recurrence in tamoxifen-treated patients
12/21/12
Garlic compound induces programmed cell death in ER+/PR+ cells
12/09/12
Tamoxifen treatment for 10 years helps prevent late recurrence
10/17/12
Pomegranate juice inhibits metastatic processes in BC cells
10/14/12
Fatty fish compound DHA increases Adriamycin efficacy in TN cells
08/20/12
High circulating vitamin B6 linked to lower risk of ER+/PR+ BC
08/12/12
Lymph node negative ER-/PR- BC has less favorable prognosis
06/20/12
Large breast size linked to reduced survival for ER+ breast cancer
05/15/12
Blueberries and raspberries both reduce mammary tumor development
05/06/12
What are the characteristics of BC with low risk of recurrence?
04/12/12
Five-year prognosis by breast cancer subtype
02/22/12
Selenium increases effectiveness of Taxol for TN breast cancer
02/20/12
Cruciferous vegetable consumption linked to reduced risk of cancer
01/17/12
Apigenin increases effectiveness of Taxol chemotherapy
12/07/11
Modern chemotherapy reduces BC death by about a third
12/02/11
Knowing receptor status of metastases improves treatment decisions
11/17/11
Brown seaweed compound fucoidan induces breast cancer cell death
11/05/11
Luminal BC prognosis can vary based on other tumor characteristics
10/22/11
Young breast cancer patients require aggressive treatment
10/20/11
Age and breast cancer subtype influence prognosis after lumpectomy
09/11/11
Calycosin in astragalus root (huang qi) promotes ER+ proliferation
08/17/11
Genistein stimulates aromatase activity and ER+ BC cell growth
08/16/11
Pomegranate fruit may help prevent estrogen sensitive breast cancer
08/01/11
BC subtype influences prognosis after neoadjuvant chemotherapy
07/17/11
Increasing aromatase inhibitor side effects make tamoxifen attractive
06/18/11
Bisphenol A promotes mammary cancer in mice
06/09/11
Patients with ER-/PR+ breast cancer benefit from endocrine therapy
05/10/11
Apigenin may prevent BC that develops in response to progestin
03/02/11
Risk of second primary breast cancer highest in ER-/PR- survivors
11/30/10
Small triple negative tumors have worse prognosis than small ER+/PR+
11/14/10
Blueberry compound pterostilbene increases effectiveness of tamoxifen
07/16/10
Quercetin supplementation may promote breast cancer
02/05/10
Vitamin D and calcium intakes influence risk of breast cancer

Studies